Announced Thu, 16 Jul · 18:32 IST
Nephrocare Health 17th AGM notice on August 12, 2026
Board & Shareholder Meetings View source PDF
NEPHROPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.3%1-day move
₹639.00
prior close
₹632.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.3-0.3-0.3-1.3-1.9+5.5+5.8+5.8—————
Up moveDown movePending
AI summary
Nephrocare Health Services (NephroPlus) has called its 17th AGM on August 12, 2026 at 2:30 PM via video conferencing. Resolutions include FY26 audited financials adoption, re-appointment of nominee director Gaurav Sharma, new ESOP 2026 scheme for up to 20.06 lakh stock options at Rs 2 face value, ESOPs for subsidiary staff, clarificatory amendment to CMD Vikram Vuppala pay, and promote incentive arrangement between founder and investors. E-voting cut-off is August 5, 2026.
Likely market impact
Shareholders can vote by e-voting. New ESOP scheme may dilute equity. Promote incentive does not cost the company.